Evidence map›Paper›PMID 26315217›Full record

ArticleScientific reports2015

Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community.

Hirosuke Sugahara, Toshitaka Odamaki, Shinji Fukuda, Tamotsu Kato, Jin-zhong Xiao, Fumiaki Abe, Jun Kikuchi, Hiroshi Ohno

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03418857 (The Role of Probiotics in Attenuating Inflammation and Improving Gut Health in Obese Adults), which is not on this map. Cited by 86 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 3 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03418857 phase1 / phase2recruitingnot on this mapstarted 2018, after this paper: background citation

The Role of Probiotics in Attenuating Inflammation and Improving Gut Health in Obese Adults

TypeinterventionalSponsorPenn State UniversityRan2018 to 2022Enrolled40ConditionsMetabolic SyndromeArmsYogurt smoothie with BB-12, Yogurt smoothie
3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 3 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Therapeutic Potential ofInternational journal of molecular sciences · 2025
    Trial
  5. Trial
  6. Science advances · 2023
    Trial
  7. Trial
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. First Report on the Frequency and Subtype Distribution ofAnimals : an open access journal from MDPI · 2025
    Article
  16. Therapeutic Potential ofInternational journal of endocrinology · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hirosuke SugaharaFood Science and Technology Institute, Morinaga Milk Industry Co., Ltd., Zama, Kanagawa, Japan.
Toshitaka OdamakiFood Science and Technology Institute, Morinaga Milk Industry Co., Ltd., Zama, Kanagawa, Japan.
Shinji FukudaRIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Tamotsu KatoRIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Jin-zhong XiaoFood Science and Technology Institute, Morinaga Milk Industry Co., Ltd., Zama, Kanagawa, Japan.
Fumiaki AbeFood Science and Technology Institute, Morinaga Milk Industry Co., Ltd., Zama, Kanagawa, Japan.
Jun KikuchiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Hiroshi OhnoRIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Yokohama City University · JPKeio University · JPRIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics are well known as health-promoting agents that modulate intestinal microbiota. However, the molecular mechanisms underlying this effect remain unclear. Using gnotobiotic mice harboring 15 strains of predominant human gut-derived microbiota (HGM), we investigated the effects of Bifidobacterium longum BB536 (BB536-HGM) supplementation on the gut luminal metabolism. Nuclear magnetic resonance (NMR)-based metabolomics showed significantly increased fecal levels of pimelate, a precursor of biotin, and butyrate in the BB536-HGM group. In addition, the bioassay revealed significantly elevated fecal levels of biotin in the BB536-HGM group. Metatranscriptomic analysis of fecal microbiota followed by an in vitro bioassay indicated that the elevated biotin level was due to an alteration in metabolism related to biotin synthesis by Bacteroides caccae in this mouse model. Furthermore, the proportion of Eubacterium rectale, a butyrate producer, was significantly higher in the BB536-HGM group than in the group without B. longum BB536 supplementation. Our findings help to elucidate the molecular basis underlying the effect of B. longum BB536 on the gut luminal metabolism through its interactions with the microbial community.

Indexed as

AnimalsBifidobacteriumBiotinFecesGastrointestinal TractGene Expression RegulationGerm-Free LifeHumansMagnetic Resonance SpectroscopyMetabolomeMetabolomicsMiceMicrobiotaProbioticsRNA, MessengerSolubilityBiotinRNA, MessengerWater

Identifiers

PMID26315217
PMCPMC4552000
OpenAlexW2408795218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.